Hextar Healthcare Berhad (KLSE:HEXCARE)
Malaysia · Delayed Price · Currency is MYR 0.0600
0.00 (0.00%)
At close: Aug 11, 2026
Hextar Healthcare Berhad Financials Overview
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 143.77 | 150.35 | 149.59 | 156.91 | 180.38 | 514.67 |
Revenue Growth | -2.12% | 0.51% | -4.67% | -13.01% | -64.95% | 23.53% |
Gross Profit Gross Profit Growth | 58.16 | 56.66 | 68.89 | 57.39 | 57.21 | 354.58 |
Operating Income Operating Income Growth | -18.46 | -19.59 | -20.28 | -63.14 | -43 | 229.96 |
Net Income Net Income Growth | -43.93 | -44.5 | -13.92 | -64.38 | -55.69 | 185.74 |
Earnings Per Share EPS Growth | -0.04 | -0.04 | -0.01 | -0.06 | -0.06 | 0.22 |
EPS Growth | - | - | - | - | - | 33.42% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Gloves Operation Gloves Operation Growth | 161.5 | 161.67 | 177.45 | 216.47 |
Medical Devices Operation Medical Devices Operation Growth | 7.48 | 9.83 | 8.2 | 5.11 |
Investment Holding Investment Holding Growth | 30.21 | 0.71 | 0.71 | - |
Eliminations Eliminations Growth | -51.07 | -25.26 | -31.6 | -46.61 |
Total Total Growth | 148.11 | 146.95 | 156.49 | 179.04 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 31.87 | 23.87 | 9.22 | 26.06 | 92.33 | 298.39 |
Total Debt Total Debt Growth | 3.73 | 2.31 | 3.73 | 5.64 | 6.78 | 1.87 |
Net Cash (Debt) Net Cash Growth | 28.14 | 21.56 | 5.49 | 20.42 | 85.54 | 296.52 |
Net Cash Growth | - | 292.81% | -73.11% | -76.13% | -71.15% | 87.02% |
Net Cash Per Share Net Cash Per Share Growth | 0.03 | 0.02 | 0.01 | 0.02 | 0.10 | 0.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 38.72 | 18.96 | -17.24 | -23.34 | -20.31 | 134.31 |
Capital Expenditures CapEx Growth | -6.3 | -6.51 | -5.15 | -5.4 | -14.65 | -35.22 |
Free Cash Flow Free Cash Flow Growth | 32.43 | 12.44 | -22.39 | -28.74 | -34.96 | 99.09 |
Free Cash Flow Growth | - | - | - | - | - | 24.33% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.45% | 37.69% | 46.06% | 36.57% | 31.71% | 68.89% |
Operating Margin | -12.84% | -13.03% | -13.56% | -40.24% | -23.84% | 44.68% |
Pretax Margin | -23.69% | -23.58% | -12.69% | -46.93% | -35.02% | 46.01% |
Profit Margin | -30.55% | -29.60% | -9.30% | -41.03% | -30.87% | 36.09% |
FCF Margin | 22.55% | 8.28% | -14.97% | -18.32% | -19.38% | 19.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 2.45 |
Forward PE | - | 2.08 | 2.08 | 2.08 | 2.08 | 2.08 |
P/FCF Ratio | 2.04 | 8.41 | - | - | - | 4.59 |
PS Ratio | 0.46 | 0.70 | 1.33 | 1.85 | 2.06 | 0.88 |